Today, cancer treatment is not the same for every patient. In recent developments, drugs are administered after testing the genetic mutations. For instance, in the case of non-small cell lung cancer (NSCLC), if there are mutations in EGFR, then a targeted drug is used to act directly on the causes of cancer growth but not generic treatments such as chemotherapy.
Why Doctors Recommend Afatinib?
Doctors mostly recommend this therapy due to its targeted approach and and proven effectiveness in EGFR mutation-positive NSCLC.
- The medicine is created especially for patients with EGFR mutation.
- It prevents the formation of tumors inside the body.
- Usually used as a first-line treatment option.
- Gives better results than non-targeted therapy.
- The medicine is preferred in case of EGFR mutation when confirmed by tests.
What is the mechanism of action?
The medicine work by blocking a protein known as EGFR, which is responsible for the proliferation of cancer cells. It prevents the development of tumors through inhibition of the cell signal transduction pathway that promotes the growth of cancerous cells. As a result, it helps in the progression of cancer.
What is the dose and duration of the medication?
The tablet should be swallowed in the form of a pill, normally once a day. It is always recommended that it should be taken on an empty stomach and at a certain time each day. The use of the drug should be continued as long as it continues being effective. Consistent use of the medicine is crucial for optimal results.
Is the medicine easily available in India and other countries?
This tablet is readily available and can be purchased from authorized pharmacies in India. It is available in various other countries like the United States of America, United Kingdom, and Australia to make ease for the individual in their cancer treatment journey. Patients can also Buy Afatinib 40mg Tablet Online from Magicine Pharma by using under a doctor prescription .
Conclusion
The medicine ‘Afatinib’ is highly recommended for non-small cell lung cancer patients who carry EGFR mutation in their genes. Doctors recommend this drug as it can target cancer growth effectively. If the medicine availability is concerned, the tablet is available throughout India as well as other parts of the world with appropriate guidance from the medical practitioner.
FAQs
1. How long will the therapy continue?
The use of the medicine will be continued for as long as the patient benefits from the therapy and does not experience serious adverse effects from it.
2. Is the drug better compared to chemotherapy?
Yes, Afatinib is better for patients with EGFR-mutated NSCLC since it targets the the protein who is responsible in the growth of cancer cells.
